Literature DB >> 12904808

Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction.

L Petrone1, E Mannucci, G Corona, M Bartolini, G Forti, R Giommi, M Maggi.   

Abstract

The aim of the present study is the definition of a brief structured interview (SI) providing scores useful for identification and quantification of pathogenetic factors of erectile dysfunction (ED). A SI was developed and applied to a consecutive series of 320 ED patients. A 13-item SI, with three-factor analysis-derived scales, was identified and applied for validation to an independent consecutive series of 194 ED patients. PGE(1) (10 microg) intracavernosal injection, penile duplex ultrasound (PDU), blood hormones, PSA, glycemia, and lipids were used for the assessment of an organic component (OC), and Middlesex Hospital Questionnaire (MHQ) modified for psychological disturbances. Scale 1, dealing with OC, showed a positive correlation with age, BMI, blood pressure, glycemia, and inverse correlation, with testosterone, PGE(1) and several parameters derived from PDU. Scale 2, related to partner's relationship, was not correlated with organic parameters. Scale 3, which measures psychopathological traits was correlated with MHQ scales. Scale 1 (>3) had a sensitivity of 67.9% and a specificity of 67.6% for OC. SIEDY((c)) provides information on ED pathogenesis and might assist physicians in diagnostic and therapeutic choices.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904808     DOI: 10.1038/sj.ijir.3901006

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  27 in total

1.  Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.

Authors:  G Corona; E Mannucci; A D Fisher; F Lotti; E Bandini; L Vignozzi; G Balercia; F Paggi; L Petrone; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

2.  SIAMS survey on sexological screening during the assisted reproductive technologies in Italy.

Authors:  G Ciocca; E Limoncin; D Mollaioli; G L Gravina; E Carosa; S Di Sante; D Gianfrilli; F Lombardo; A Lenzi; E A Jannini
Journal:  J Endocrinol Invest       Date:  2015-04-18       Impact factor: 4.256

Review 3.  The role of testosterone in erectile dysfunction.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

Review 4.  Male sexual dysfunction and HIV--a clinical perspective.

Authors:  Daniele Santi; Giulia Brigante; Stefano Zona; Giovanni Guaraldi; Vincenzo Rochira
Journal:  Nat Rev Urol       Date:  2014-01-07       Impact factor: 14.432

5.  Testosterone and cardiovascular risk in patients with erectile dysfunction.

Authors:  G Corona; G Rastrelli; G Balercia; A Sforza; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

Review 6.  The use of phosphodiesterase 5 inhibitors with concomitant medications.

Authors:  G Corona; E Razzoli; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

7.  How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.

Authors:  G Rastrelli; G Corona; M Tarocchi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-01-05       Impact factor: 4.256

Review 8.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Authors:  A Morelli; G Corona; S Filippi; S Ambrosini; G Forti; L Vignozzi; M Maggi
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 9.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

10.  Gynecomastia in subjects with sexual dysfunction.

Authors:  E Maseroli; G Rastrelli; G Corona; V Boddi; A M L Amato; E Mannucci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-02-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.